(4) MiRNA‐21a‐5p activated the downstream TGFBR1/SMAD2/3 signaling pathway by suppressing the expression of the target gene RBMS3 in both cell and animal models of TIA. This evidence concerns the gene SMAD2 and transient ischemic attack.